| Literature DB >> 26713883 |
Akifumi Nozawa1, Michio Ozeki1, Bunya Kuze2, Takahiko Asano3, Kentaro Matsuoka4, Toshiyuki Fukao1.
Abstract
Gorham-Stout disease (GSD) is a rare disorder of unknown etiology. We present a 6-year-old male with GSD involving the skull base who presented with recurrent cerebrospinal fluid (CSF) rhinorrhea, severe hearing loss, and facial palsy secondary to cerebellar herniation into the internal auditory canal. After 2 months of treatment with pegylated interferon (IFN) α-2b (50 μg/week), his hearing recovered dramatically. Two years later, new bone formation appeared radiologically and IFN was switched to sirolimus. One year after the switch, CSF rhinorrhea disappeared. Antiangiogenic therapy might inhibit proliferation of vascular endothelial cells in osteolytic lesions and lead to new bone formation.Entities:
Keywords: cerebrospinal fluid leakage; interferon; lymphatic malformation; mammalian target of rapamycin; sirolimus
Mesh:
Substances:
Year: 2015 PMID: 26713883 DOI: 10.1002/pbc.25886
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167